Eosinophilic Disease

Disease State Hub

FDA Alerts

treatment

FDA Approves First EoE Treatment

05/28/2022

The FDA has approved the first treatment for eosinophilic esophagitis.

05/28/2022

asthma

FDA Approves New Option for Severe Eosinophilic Asthma

11/15/2017

The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.

11/15/2017

Research Summaries

Conference Coverage

Eosinophilia Common During IL-1, IL-6 Use in Patients With sJIA, non-sJIA

11/30/2022

The researchers examined the incidence rates, risk factors, and outcomes for IL-1 and IL-6 inhibitors in patients with systemic and non-systemic juvenile idiopathic arthritis.

11/30/2022

treatment

Exacerbations Increased After Discontinuing Long-term Use of Mepolizumab for Severe Eosinophilic Asthma

08/19/2022

While the long-term safety and efficacy of mepolizumab have been studied, gaps in the literature have remained on the clinical impact of stopping mepolizumab after long-term use. Researchers examined how...

08/19/2022

Airway

Airway Differentiation for Eosinophilic Diseases

05/31/2022

Researchers examined how airway differentiation of eosinophilic progenitor cells may impact non-asthmatic eosinophilic bronchitis and eosinophilic asthma.

05/31/2022

treatment

FDA Approves First EoE Treatment

05/28/2022

The FDA has approved the first treatment for eosinophilic esophagitis.

05/28/2022

symptoms

Dilation, Eosinophils in Eosinophilic Esophagitis

04/30/2022

Dilation of the esophagus is often used to manage symptoms of dysphagia in patients with eosinophilic esophagitis, but the relationship between dilation, eosinophil concentration, and symptoms in these...

04/30/2022

October 2024

Current Issue

October 2024

Volume 64

Issue 9